Macquarie Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$658K Hold
899,999
﹤0.01% 1433
2025
Q1
$726K Hold
899,999
﹤0.01% 1428
2024
Q4
$1.24M Hold
899,999
﹤0.01% 1311
2024
Q3
$936K Hold
899,999
﹤0.01% 1392
2024
Q2
$1.56M Hold
899,999
﹤0.01% 1288
2024
Q1
$2.15M Buy
899,999
+250,000
+38% +$598K ﹤0.01% 1199
2023
Q4
$2.17M Buy
649,999
+151,400
+30% +$504K ﹤0.01% 1199
2023
Q3
$1.87M Buy
498,599
+68,599
+16% +$257K ﹤0.01% 1177
2023
Q2
$1.84M Hold
430,000
﹤0.01% 1205
2023
Q1
$2.94M Hold
430,000
﹤0.01% 1045
2022
Q4
$3.41M Sell
430,000
-591
-0.1% -$4.68K ﹤0.01% 1054
2022
Q3
$4.15M Sell
430,591
-784
-0.2% -$7.55K 0.01% 1038
2022
Q2
$3.12M Hold
431,375
﹤0.01% 1150
2022
Q1
$5.57K Hold
431,375
﹤0.01% 1088
2021
Q4
$6.89M Hold
431,375
0.01% 1043
2021
Q3
$6.93M Hold
431,375
0.01% 1014
2021
Q2
$5.97M Hold
431,375
﹤0.01% 1081
2021
Q1
$6.3M Sell
431,375
-371
-0.1% -$5.42K 0.01% 852
2020
Q4
$7.5M Hold
431,746
0.01% 787
2020
Q3
$7.92M Hold
431,746
0.01% 705
2020
Q2
$7.71M Buy
431,746
+1,746
+0.4% +$31.2K 0.01% 682
2020
Q1
$6.98M Hold
430,000
0.01% 639
2019
Q4
$7.74M Hold
430,000
0.01% 698
2019
Q3
$8.71M Hold
430,000
0.01% 632
2019
Q2
$9.5M Hold
430,000
0.02% 615
2019
Q1
$5.87M Sell
430,000
-300
-0.1% -$4.09K 0.01% 734
2018
Q4
$3.9M Hold
430,300
0.01% 815
2018
Q3
$7.1M Sell
430,300
-2,700
-0.6% -$44.6K 0.01% 710
2018
Q2
$6.06M Buy
433,000
+13,000
+3% +$182K 0.01% 736
2018
Q1
$4.64M Buy
420,000
+23,700
+6% +$262K 0.01% 776
2017
Q4
$3.49M Buy
396,300
+106,300
+37% +$935K 0.01% 871
2017
Q3
$3.87M Sell
290,000
-20,923
-7% -$279K 0.01% 819
2017
Q2
$4.46M Buy
310,923
+263,168
+551% +$3.78M 0.01% 775
2017
Q1
$1.01M Buy
47,755
+5,200
+12% +$110K ﹤0.01% 1177
2016
Q4
$1.2M Sell
42,555
-15,700
-27% -$442K ﹤0.01% 1115
2016
Q3
$1.56M Sell
58,255
-52,855
-48% -$1.42M ﹤0.01% 1031
2016
Q2
$1.88M Buy
+111,110
New +$1.88M ﹤0.01% 1158